AzTrials
AzTrials

Traumatic Brain InjuryNCT04553848

Augmented Reality and Treadmill Training After Traumatic Brain Injury

A study testing Augmented Reality and Treadmill training in people with Traumatic Brain Injury, run by Craig Hospital at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Up to 40 participants will be enrolled in this study in order to obtain complete data on 30 participants. The investigators will be assessing if Augmented reality in combination with treadmill training is safe and feasible to use in the clinical environment with participants who have chronic TBI and if there is a… Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Traumatic Brain Injury
What is being tested?
Augmented Reality and Treadmill training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
31 participants
Where
1 siteUnited States
Study dates
19 Oct 2020to 1 Oct 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Sustained a TBI requiring inpatient rehabilitation
  • > 1 year post TBI
  • 18-65 years of age
  • Not currently participating in any other research study to address balance and gait impairment
  • Not currently participating in physical therapy
  • Ambulates with minimal assistance and/or assistive device
Show all 12Show fewer
  • Self-report of ongoing balance deficits and mobility deficits
  • Score of 75 or below on CB\&M
  • No history of other neurological disorders affecting balance
  • No seizures within the last year
  • No history of psychiatric disorder requiring hospitalization
  • Ability to follow directions and complete standardized instructions

Who cannot join

  • No pregnant or lactating females (Potential female participants will be informed that risks to pregnant or lactating females are unknown; then they will be asked if they are pregnant or lactating, or if they could be pregnant. If there is any uncertainty, they will not be included in the study).

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Craig Hospital

    Englewood, Colorado, 80113

Other trials in United States

About this study

Up to 40 participants will be enrolled in this study in order to obtain complete data on 30 participants. The investigators will be assessing if Augmented reality in combination with treadmill training is safe and feasible to use in the clinical environment with participants who have chronic TBI and if there is a signal of effect that this intervention may be more beneficial than treadmill training alone or standard of care.

Being tested
Augmented Reality, Treadmill training, Over ground training/standard of care
Medical subject headings
Brain Injuries, Traumatic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Augmented RealityBehavioural

    Augmented Reality (AR) systems are computer-based applications that allow an individual to view a simulated environment and dynamically interact within this environment in real-time. Augmented reality activities will be chosen by the therapist based on the primary deficits assessed during baseline testing.

  • Treadmill trainingBehavioural

    The goal of each session will be to increase balance and mobility challenge by increasing speed and minimizing BWS. Appropriate BWS will be chosen at the beginning of each training session. Participants will walk for 1 minute on the treadmill at 30%, 20% and 10% BWS. Maximum walking speed will be determined at each level of BWS and the participant will spend the remainder of the session ambulating with BWS at which they were able to achieve maximum walking speed. Additional BWS will be provided up to 30% of the participant's total body weight if the treating therapist identifies safety concerns or unfavorable gait kinematics. If a safe and kinematically appropriate gait pattern is unable to be achieved at up to 30% BWS, the previously determined walking speed will be reduced to achieve a safe and appropriate walking pattern. Participants will be encouraged not to use upper extremity support while ambulating with BWS.

  • Over ground training/standard of careBehavioural

    Standard of care interventions to address balance and mobility deficits will be chosen from a list of commonly used interventions in outpatient therapy. The goal of each session will be to increase balance and mobility challenge in an over ground condition focusing treatment in the following areas:

    • Biomechanical Constraints
    • Stability Limits
    • Anticipatory Postural Adjustments
    • Reactive Postural Response
    • Sensory Orientation
    • Stability in Gait
Study groups in NCT04553848
Study groupRoleWhat they receive
Augmented Reality+ Treadmill trainingExperimentalParticipants allocated to this group will receive treadmill training with body weight support (BWS) incorporating augmented feedback games chosen to address clinically perceived deficits using the C-Mill training system.
Receives: Behavioral: Augmented Reality; Behavioral: Treadmill training
Treadmill trainingActive comparatorParticipants allocated to this group will receive treadmill training with body weight support (BWS) using the C-Mill training system.
Receives: Behavioral: Treadmill training
Over ground training/standard of careActive comparatorParticipants allocated to this group will receive over ground balance and mobility training that would be considered standard of care in outpatient rehabilitation.
Receives: Behavioral: Over ground training/standard of care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Community Balance and Mobility Scale

    13 activities scored from 0-96, higher numbers reflect greater balance

    Measured: Baseline to Week 8

Secondary outcomes (14)
  1. 10 meter walk test

    total time to walk 10 meters

    Measured: Baseline, Week 4, and Week 8

  2. 6 minute walk test

    distance walked in 6 minutes

    Measured: Baseline, Week 4, and Week 8

  3. Timed Up and Go

    received verbal instructions to stand up from chair, walk 3 meters, cross a line marked on the floor, turn around, walk back and sit down

    Measured: Baseline, Week 4, and Week 8

  4. Timed Up and Go Cognitive Test

    receive verbal instructions to stand up from a chair, walk 3 meters, cross a line marked on the floor, turn around, walk back and sit down while counting backward by threes from a randomly selected number between 20 and 100

    Measured: Baseline, Week 4, and Week8

  5. Timed Up and Go Manual

    receive verbal instructions to stand up from a chair, walk 3 meters as quickly and safely as possible, cross a lined marked on the floor, turn around, walk back and sit down while holding a cup filled with water

    Measured: Baseline, Week 4, and Week 8

  6. Activities-Specific Confidence Scale

    16 item measure, scored from 0 to 100. Higher scores reflect great confidence of task

    Measured: Baseline, Week 4, and Week 8

  7. CNS Vital Signs - Psychomotor Speed Domain

    In-office neurocognitive test that is a non-invasive clinical procedure designed to efficiently and objectively assess a broad spectrum of brain function performance or domains under challenge. Finger tapping test and symbol digit coding will be aggregated to arrive at one reported value representing the psychomotor speed domain. Above average domain scores indicate a standard score (SS) greater than 109 or a Percentile Rank (PR) greater than 74, indicating a high functioning test subject. Average is a SS 90-109 or PR 25-74, indicating normal function. Low Average is a SS 80-89 or PR 9-24 indicating a slight deficit or impairment. Below Average is a SS 70-79 or PR 2-8, indicating a moderate level of deficit or impairment. Very Low is a SS less than 70 or a PR less than 2, indicating a deficit and impairment.

    Measured: Baseline, Week 4, and Week 8

  8. CNS Vital Signs - Executive Functioning Domain

    In-office neurocognitive test that is a non-invasive clinical procedure designed to efficiently and objectively assess a broad spectrum of brain function performance or domains under challenge. Shifting attention score will represent the executive functioning domain. Above average domain scores indicate a standard score (SS) greater than 109 or a Percentile Rank (PR) greater than 74, indicating a high functioning test subject. Average is a SS 90-109 or PR 25-74, indicating normal function. Low Average is a SS 80-89 or PR 9-24 indicating a slight deficit or impairment. Below Average is a SS 70-79 or PR 2-8, indicating a moderate level of deficit or impairment. Very Low is a SS less than 70 or a PR less than 2, indicating a deficit and impairment.

    Measured: Baseline, Week 4, and Week 8

  9. CNS Vital Signs - Reaction Time Domain

    In-office neurocognitive test that is a non-invasive clinical procedure designed to efficiently and objectively assess a broad spectrum of brain function performance or domains under challenge. Stroop test score will represent the reaction time domain. Above average domain scores indicate a standard score (SS) greater than 109 or a Percentile Rank (PR) greater than 74, indicating a high functioning test subject. Average is a SS 90-109 or PR 25-74, indicating normal function. Low Average is a SS 80-89 or PR 9-24 indicating a slight deficit or impairment. Below Average is a SS 70-79 or PR 2-8, indicating a moderate level of deficit or impairment. Very Low is a SS less than 70 or a PR less than 2, indicating a deficit and impairment.

    Measured: Baseline, Week 4, and Week 8

  10. CNS Vital Signs - Cognitive Flexibility Domain

    In-office neurocognitive test that is a non-invasive clinical procedure designed to efficiently and objectively assess a broad spectrum of brain function performance or domains under challenge. Shifting attention test and Stroop test scores will be aggregated to arrive at one reported value representing the cognitive flexibility domain. Above average domain scores indicate a standard score (SS) greater than 109 or a Percentile Rank (PR) greater than 74, indicating a high functioning test subject. Average is a SS 90-109 or PR 25-74, indicating normal function. Low Average is a SS 80-89 or PR 9-24 indicating a slight deficit or impairment. Below Average is a SS 70-79 or PR 2-8, indicating a moderate level of deficit or impairment. Very Low is a SS less than 70 or a PR less than 2, indicating a deficit and impairment.

    Measured: Baseline, Week 4, and Week 8

  11. Physical Activity Enjoyment Scale

    scale of participant enjoyment in the moment. 7-point bipolar rating scale, eleven items are reverse scored. Higher total score reflect greater levels of enjoyment

    Measured: Week 1, Week 2, Week 3, and Week 4

  12. Global Impression of Change

    9 point Likert scale. Higher positive score reflects great improvement

    Measured: Week 1, Week 2, Week 3, Week 4, and Week 8

  13. Heart Rate

    heart rate beats per minute

    Measured: Baseline, Week 1, Week 2, Week 3, Week 4, and Week 8

  14. Blood Pressure

    systolic and diastolic, mm/Hg

    Measured: Baseline, Week 1, Week 2, Week 3, Week 4, and Week 8

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Sep 2020
  2. Study start19 Oct 2020
  3. Primary completion1 Oct 2021
  4. Study completion1 Oct 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
31 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04553848
Sponsor's protocol ID
1606744
Status last verified
Jan 2022
First submitted
3 Sep 2020
Last updated
28 Jan 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Augmented Reality and Treadmill training in people with Traumatic Brain Injury, run by Craig Hospital at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 12 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Jan 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Community Balance and Mobility Scale (time frame: Baseline to Week 8). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jan 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in